Covis Group S.à r.l. ("Covis") and AMAG Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which Covis will acquire AMAG for $13.75 per share in cash. (10/1/20)
I doubt you'll see a further price rise after this news item.
I doubt you'll see a further price rise after this news item.